Semi-Annual Statement Of Income

STELLA PHARMA CORPORATION - Filing #7371918

Concept 2023-04-01 to
2023-09-30
2022-04-01 to
2022-09-30
Semi-annual statement of income
Statement of income
Net sales
153,995,000 JPY
92,397,000 JPY
Cost of sales
30,922,000 JPY
6,373,000 JPY
Ordinary profit (loss)
-303,679,000 JPY
-342,330,000 JPY
Gross profit (loss)
123,072,000 JPY
86,023,000 JPY
Selling, general and administrative expenses
424,305,000 JPY
452,573,000 JPY
Extraordinary losses
750,000 JPY
JPY
Selling, general and administrative expenses
Profit (loss) before income taxes
-304,430,000 JPY
-342,330,000 JPY
Operating profit (loss)
-301,233,000 JPY
-366,550,000 JPY
Non-operating income
857,000 JPY
25,727,000 JPY
Income taxes - current
1,425,000 JPY
1,815,000 JPY
Non-operating income
Interest income
724,000 JPY
719,000 JPY
Income taxes
1,425,000 JPY
1,815,000 JPY
Non-operating expenses
3,303,000 JPY
1,507,000 JPY
Profit (loss)
-305,856,000 JPY
-344,145,000 JPY
Non-operating expenses
Interest expenses
1,061,000 JPY
1,391,000 JPY
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.